한국유니온제약(주)

ETC

Rosutatin Tab. 20mg

Active Ingredients: Rosuvastatin 20mg

Indications: 1. Primary hypercholesterolemia (type Ⅱa including heterozygous familial hypercholesterolemia), complex hyperlipidemia (type Ⅱb): Dietary supplements if they cannot be controlled by diet and exercise 2. Adjuvant of diet or other lipid-lowering therapy (eg, LDL separation) for homozygous familial hypercholesterolemia 3. Delayed progression of atherosclerosis in patients with hypercholesterolemia by lowering total cholesterol and LDL-cholesterol to target levels 4. Dierary supplements to reduce chloesterol, LDL-cholesterol and Apo-B protein levels in patients aged 10 ~ 17 years (female at least one year after menarche) with heterozygous family hypercholesterolemia, which still meets the following criteria, despite the diet 1) LDL-cholesterol still exceeds 190 mg/dL (LDL-C>190 mg/dL) 2) LDL-cholesterol still exceeds 160 mg/dL (LDL-C>160 mg/dL), with a family history of early cardiovascular disease or at least two cardiovascular disease risk factors 5. Dietary supplements in patients with primary abnormal betalipoproteinemia (type III) 6. Reduced risk of cardiovascular disease: There is no clinical evidence of coronary heart disease, but men over 50 years of age and women over 60 years of age have a high sensitivity of C-reactive protein (hsCRP) of 2 mg/L and at least one additional cardiovascular risk factor (eg, high blood pressure, low HDL-cholesterol levels, smoking, or family history of early coronary heart disease); 1) Reduced risk of stroke 2) Reduced risk of myocardial infarction 3) Reduced risk of arterial angioplasty

ETC

Rosutatin Tab. 5mg

Active Ingredients: Rosuvastatin 5mg

Indications: 1. Primary hypercholesterolemia (type Ⅱa including heterozygous familial hypercholesterolemia), complex hyperlipidemia (type Ⅱb): Dietary supplements if they cannot be controlled by diet and exercise 2. Adjuvant of diet or other lipid-lowering therapy (eg, LDL separation) for homozygous familial hypercholesterolemia 3. Delayed progression of atherosclerosis in patients with hypercholesterolemia by lowering total cholesterol and LDL-cholesterol to target levels 4. Dierary supplements to reduce chloesterol, LDL-cholesterol and Apo-B protein levels in patients aged 10 ~ 17 years (female at least one year after menarche) with heterozygous family hypercholesterolemia, which still meets the following criteria, despite the diet 1) LDL-cholesterol still exceeds 190 mg/dL (LDL-C>190 mg/dL) 2) LDL-cholesterol still exceeds 160 mg/dL (LDL-C>160 mg/dL), with a family history of early cardiovascular disease or at least two cardiovascular disease risk factors 5. Dietary supplements in patients with primary abnormal betalipoproteinemia (type III) 6. Reduced risk of cardiovascular disease: There is no clinical evidence of coronary heart disease, but men over 50 years of age and women over 60 years of age have a high sensitivity of C-reactive protein (hsCRP) of 2 mg/L and at least one additional cardiovascular risk factor (eg, high blood pressure, low HDL-cholesterol levels, smoking, or family history of early coronary heart disease); 1) Reduced risk of stroke 2) Reduced risk of myocardial infarction 3) Reduced risk of arterial angioplasty

ETC

Serokfen Tab.

Active Ingredients: Loxoprofen Sodium Hydrate 68.1mg

Indications: 1. Anti-inflammatory and analgesic of the following diseases and symptoms Chronic rheumatoid arthritis, osteoarthritis (degenerative arthritis), low back pain, frozen shoulder, cervical syndrome 2. Anti-inflammatory and analgesic after surgery, after trauma and extraction 3. Antipyretic and analgesia of the following diseases Acute upper respiratory tract infection (including acute upper respiratory tract infection with acute bronchitis)

Antibiotics

Teonam Inj. 500mg

Active Ingredients: Imipenem Hydrate 500mg + Cilastatin Sodium 500mg

Indications: 1. Effective species Staphylococcus, streptococcus, E. coli, citrobacter, klebsiella, enterobacter, serratia, furoteus, pseudomonas, influenza bacteria, acinetobacter, bacteroid, peptococci 2. Indications 1) Bronchitis, bronchiectasis (when infected), secondary infection of chronic respiratory disease, pneumonia, lung abscess, empyema 2) Pyelonephritis, cystitis, prostatitis 3) Cholecystitis, cholangitis, liver abscess, peritonitis 4) Endometritis, uterine adnexitis, pelvic antagonitis, cervical spondylitis 5) Sepsis 6) Infective endocarditis 7) Osteomyelitis 8) Arthritis 9) Secondary infection of the wound 10) Ophthalmitis, corneal ulcer 11) Bartholinitis

Antibiotics

Topracin Inj.

Active Ingredients: Tobramycin 40mg/mL

Indications: 1. Effective species Pseudomonas aeruginosa, proteus, E. coli, klebsiella, enterobacter, serratia, citrobacter, providencia, staphylococcus aureus 2. Indications 1) Central nervous system infections such as meningitis 2) Bronchitis, bronchiectasis (when infected), pneumonia 3) Gastrointestinal infections such as peritonitis 4) Subcutaneous abscess, furuncle, soft tissue, 5) Burns, postoperative wound infections, osteoinfections 6) Sepsis 7) Pyelonephritis, cystitis (infection due to severe mixing and relapse)

Cardiovascular

Tratazine Tab.

Active Ingredients: Trimetazidine HCl 20mg

Indications: 1. Cardiovascular system: Angina 2. Ophthalmology: Choroidal retinopathy due to ischemia 3. Otolaryngology: Vascular dizziness, Meniere's dizziness, tinnitus

ETC

Uni-Infusion Inj. 500mg

Active Ingredients: L-Ornithine-L-Aspartate 500mg/5mL

Indications: Severe liver disease detoxification: Hepatitis, hepatitis sequelae, tissue damage, cirrhosis

ETC

Uni-Infusion Inj. 5g

Active Ingredients: L-Ornithine-L-Aspartate 5g/10mL

Indications: Detoxification of severe liver disease: Hepatic encephalopathy (including pre-coma and coma)

한국유니온제약(주)

Product Information

All